Analysis of the diagnostic presentation profile, parathyroidectomy indication and bone mineral density follow-up of Brazilian patients with primary hyperparathyroidism

Brazilian Journal of Medical and Biological Research

Volumn 40, Issue 4, 2007, Pages 519-526

  Oliveira, U E M ^a   Ohe, M N ^a   Santos, R O ^a   Cervantes, O ^a   Abrahao M ^a   Lazaretti Castro, M ^a   Vieira, J G H ^a,b   Hauache, Omar M ^a,b  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b Fleury   (Brazil)

Author keywords

Bone mineral density; Clinical presentation; Hypercalcemia; Parathyroidectomy; Primary hyperparathyroidism

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; CREATININE; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D;

ADULT; AGE; ARTICLE; BONE DENSITY; BONE DISEASE; BONE MASS; BRAZIL; CALCIUM DEFICIENCY; CLINICAL FEATURE; CONTROLLED STUDY; DELAYED DIAGNOSIS; DEVELOPING COUNTRY; DIAGNOSTIC PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR NECK; FOLLOW UP; HEREDITY; HUMAN; HYPERCALCEMIA; KIDNEY DISEASE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; MUSCLE DISEASE; NEUROLOGIC DISEASE; NUTRITIONAL STATUS; OSTEOPOROSIS; PARATHYROIDECTOMY; PRACTICE GUIDELINE; PREMENOPAUSE; PRIMARY HYPERPARATHYROIDISM; RACE DIFFERENCE; RETROSPECTIVE STUDY; SEX DIFFERENCE; SYMPTOM; TREATMENT INDICATION; TREATMENT OUTCOME; VITAMIN D DEFICIENCY;

EID: 34247253965     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2007000400010     Document Type: Article

References (24)

1. Mallette LE, Bilezikian JP, Heath DA, Aurbach GD. Primary hyperparathyroidism: clinical and biochemical features. Medicine 1974; 53: 127-146.
2. Mundy GR, Cove DH, Fisken R. Primary hyperparathyroidism: changes in the pattern of clinical presentation. Lancet 1980; 1: 1317-1320.
3. Wermers RA, Khosla S, Atkinson EJ, Hodgson SF, O'Fallon WM, Melton LJ III. The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965-1992. Ann Intern Med 1997; 126: 433-440.
4. Bilezikian JP, Potts JT Jr. Asymptomatic primary hyperparathyroidism: new issues and new questions - bridging the past with the future. J Bone Miner Res 2002; 17 (Suppl 2): N57-N67.
5. Silverberg SJ, Bilezikian JP. Evaluation and management of primary hyperparathyroidism. J Clin Endocrinol Metab 1996; 81: 2036-2040.
6. Biyabani SR, Talati J. Bone and renal stone disease in patients operated for primary hyperparathyroidism in Pakistan: is the pattern of disease different from the west? J Pak Med Assoc 1999; 49: 194-198.
7. Bilezikian JP, Meng X, Shi Y, Silverberg SJ. Primary hyperparathyroidism in women: a tale of two cities - New York and Beijing. Int J Fertil Womens Med 2000; 45: 158-165.
8. Marcinkowski W, Nieszporek T, Kokot F, Podwinski A, Niemiec A, Wieczorek M. Clinical and biochemical picture of primary hyperparathyroidism based on 155 observed cases. Pol Arch Med Wewn 2000; 103: 61-66.
9. Mishra SK, Agarwal G, Kar DK, Gupta SK, Mithal A, Rastad J. Unique clinical characteristics of primary hyperparathyroidism in India. Br J Surg 2001; 88: 708-714.
10. Rao DS, Agarwal G, Talpos GB, Phillips ER, Bandeira F, Mishra SK, et al. Role of vitamin D and calcium nutrition in disease expression and parathyroid tumor growth in primary hyperparathyroidism: a global perspective. J Bone Miner Res 2002; 17 (Suppl 2): N75-N80.
11. Ohe MN, Santos RO, Barros ER, Lage A, Kunii IS, Abrahao M, et al. Changes in clinical and laboratory findings at the time of diagnosis of primary hyperparathyroidism in a University Hospital in São Paulo from 1985 to 2002. Braz J Med Biol Res 2005; 38: 1383-1387.
12. Consensus development conference statement. J Bone Miner Res 1991; 6 (Suppl 2): S9-S13.
13. Bilezikian JP, Potts JT Jr, Fuleihan G, Kleerekoper M, Neer R, Peacock M, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Bone Miner Res 2002; 17 (Suppl 2): N2-N11.
14. Genant HK, Grampp S, Gluer CC, Faulkner KG, Jergas M, Engelke K, et al. Universal standardization for dual X-ray absorptiometry: patient and phantom cross-calibration results. J Bone Miner Res 1994; 9: 1503-1514.
15. Adami S, Marcocci C, Gatti D. Epidemiology of primary hyperparathyroidism in Europe. J Bone Miner Res 2002; 17 (Suppl 2): N18-N23.
16. Marx SJ. Hyperparathyroid and hypoparathyroid disorders. N Engl J Med 2000; 343: 1863-1875.
17. Agarwal G, Mishra SK, Kar DK, Singh AK, Arya V, Gupta SK, et al. Recovery pattern of patients with osteitis fibrosa cystica in primary hyperparathyroidism after successful parathyroidectomy. Surgery 2002; 132: 1075-1083.
18. Miedlich S, Krohn K, Paschke R. Update on genetic and clinical aspects of primary hyperparathyroidism. Clin Endocrinol 2003; 59: 539-554.
19. Moosgaard B, Vestergaard P, Heickendorff L, Melsen F, Christiansen P, Mosekilde L. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol 2005; 63: 506-513.
20. DeLellis RA. Parathyroid carcinoma: an overview. Adv Anat Pathol 2006; 12: 53-61.
21. Vieira JG, Ohe MN, Hauache OM, Oliveira UM, Delana JM, Gonçalves A, et al. Parathyroid carcinoma. Arq Bras Endocrinol Metabol 2005; 49: 811-815.
22. Christiansen P. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture. APMIS Suppl 2001; 1-52.
23. Silverberg SJ, Shane E, Jacobs TP, Siris E, Bilezikian JP. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 1999; 341: 1249-1255.
24. Silverberg SJ, Gartenberg F, Jacobs TP, Shane E, Siris E, Staron RB, et al. Increased bone mineral density after parathyroidectomy in primary hyperparathyroidism. J Clin Endocrinol Metab 1995; 80: 729-734.